Sanne Group plc
("SANNE" or "the Company ")
Issue of Equity
As a result of the acquisition of AgenSynd, announced with our Interim Results on 11 September 2018, applications have been made to the FCA and the London Stock Exchange, respectively, for 568,986 ordinary shares of 1 pence each in the share capital of the Company (the "Shares") to be admitted to the premium listing segment of the Official List and to trading on the Main Market. It is expected that admission of the Shares will become effective and dealings in the Shares will commence on or around 13 September 2018.
Following admission of the Shares, the Company will have 145,359,856 ordinary shares of £0.01 each in issue of which 98,533 are held in treasury. Therefore, following Admission of the Shares the total number of voting rights in the Company will be 145,261,323 (the "Voting Rights Figure"), and this Voting Rights Figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their voting rights interest, or a change to that interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For and on behalf of Sanne Group plc
SANNE Group plc Tel: +44 (0)20 3911 1048
Ian Portal, Company Secretary
SANNE is a leading global provider of alternative asset and corporate services. Established for over 30 years and listed as a FTSE 250 company on the Main Market of the London Stock Exchange, SANNE employs more than 1,300 people worldwide and administers structures and funds that have in excess of £200 billion of assets.
Key clients include alternative asset managers, financial institutions, family offices, ultra-high net-worth individuals and corporates.
SANNE operates from a global network of offices located in leading financial jurisdictions, which are spread across the Americas, Europe, Africa and Asia-Pacific.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org or visit www.rns.com.